title: Re: Treatment Outcomes and Resource Use of Patients With Neurogenic Detrusor Overactivity Receiving Botulinum Toxin A (BOTOX) Therapy in Germany.
authors.forename: David F
authors.initials: DF
authors.lastname: Penson
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D017281:Cost of Illness; D005260:Female; D006801:Humans; D008297:Male; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000191:economics*
chemical_list: D019274:Botulinum Toxins, Type A